It is currently Wed Oct 01, 2014 1:44 pm

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.


Rituximab

However bad you think you have it some poor bastard has it worse. Here is an article from the Boston Cure Project about two MS horror stories where Rituximab helped.

'B' cells seem to be the culprits in these cases (not sure if 'T' cells played a role).



http://www.bostoncure.org:8080/article. ... =nocomment
Read more : Rituximab | Views : 1730 | Replies : 0


BioMS MBP8298 positive review

Good news for MBP8298 Phase II/III trial...



Data Safety Monitoring Board gives positive review for BioMS Medical's pivotal MS trial

October 27 - CNW - BioMS Medical Corp., a leading developer in the treatment of multiple sclerosis (MS), announced that following the second meeting of its independent Data Safety Monitoring Board (DSMB), the Company has received a recommendation to continue its pivotal phase II/III clinical trial for MBP8298 for the treatment of secondary progressive multiple ...
Read more : BioMS MBP8298 positive review | Views : 1331 | Replies : 0


Tysabri

This is my first post and I don't really have a clue what I am doing! I came across this "lead-in" article on the "news for the day", i.e., current, New England Journal website. It costs $29.95 to read the entire article and I really don't want to make the investment. Perhaps some of you know what this means:

Progressive Multifocal Leukoencephalopathy, Natalizumab, and Multiple Sclerosis

To the Editor: According to the established definition of ...
Read more : Tysabri | Views : 1622 | Replies : 3




Rituximab

Rituximab (rituxan) is in Phase ii trials (Biogen is the drugs company behind rituxan).

The following research paper suggests it has benefits - it affects B cells (rather than the usual T cells)

Bromley

http://www.msif.org/en/research/researc ... tabil.html
Read more : Rituximab | Views : 1243 | Replies : 0






Antisense Therapeutics

Antisense Therapeutics were trialling an oral drug which targeted the same protein as Tysabri. The company stopped the trial following the Tysabri fiasco. The company has applied to restart the trial (may need to add to Dignan's list of approval given).


http://www.antisense.com.au/dl/415.pdf
Read more : Antisense Therapeutics | Views : 1311 | Replies : 0


Updated Interim NeuroVax(TM) Data

New NeuroVax Data from the European MS Meeting


http://biz.yahoo.com/bw/051003/35350.html?.v=1



Dunmann.
Read more : Updated Interim NeuroVax(TM) Data | Views : 1386 | Replies : 0


 

Login  •  Register


Statistics

Total posts 220313 • Total topics 22802 • Total members 14389


Contact us | Terms of Service